Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Juvena Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Juvena Therapeutics

Juvena Therapeutics

Series A

Juvena Therapeutics: A biopharmaceutical platform for novel protein-based therapeutics discovery.

HQ
Palo Alto, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to restore tissue health and rejuvenate lives, Juvena Therapeutics is a biopharmaceutical platform dedicated to discovering and developing novel protein-based therapeutics. The company focuses on mapping the therapeutic potential of natural secreted proteins and engineering them into biologics that can repair protein signaling and intercellular communication. By addressing protein signaling dysregulation, Juvena aims to combat degenerative diseases and promote tissue regeneration.

Juvena Therapeutics has garnered attention from notable investors and industry experts, contributing to its rapid growth and innovation in the biopharmaceutical field. The company's pioneering approach has led to significant advancements in understanding and utilizing secreted proteins for therapeutic purposes. Juvena's impact is evident in its potential to transform treatment paradigms for degenerative diseases, offering new hope for patients through advanced biologic therapies.

Juvena Therapeutics - Similar Companies

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Juvenescence logo

Juvenescence

juvlabs.com

Biotheryx logo

Biotheryx

biotheryx.com

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Endogena Therapeutics logo

Endogena Therapeutics

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Vicinitas Therapeutics logo

Vicinitas Therapeutics

vicinitastx.com

Theradaptive logo

Theradaptive

theradaptive.com

Secretome Therapeutics logo

Secretome Therapeutics

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

EpiBiologics logo

EpiBiologics

epibiologics.com

Bonum Therapeutics logo

Bonum Therapeutics

bonumtx.com

Jengu Therapeutics logo

Jengu Therapeutics

Deciduous Therapeutics logo

Deciduous Therapeutics

deciduoustx.com

Jnana Therapeutics logo

Jnana Therapeutics

jnanatx.com

Juvena Therapeutics - Quick Facts

Who are Juvena Therapeutics' competitors?

Companies similar to Juvena Therapeutics include Juventas Therapeutics, Juvenescence, Biotheryx and Rejuveron Life Sciences.

When was Juvena Therapeutics founded?

Juvena Therapeutics was founded in 2017.

Where is Juvena Therapeutics' headquarters located?

Juvena Therapeutics' headquarters is located in Palo Alto, CA, US.

When was Juvena Therapeutics' last funding round?

Juvena Therapeutics' most recent funding round was for $41M (USD) in November 2022.

How much has Juvena Therapeutics raised to-date?

As of Nov 8, 2022, Juvena Therapeutics has raised a total of $49.2M (USD).

How many employees does Juvena Therapeutics have?

Juvena Therapeutics has 11 employees as of Feb 5, 2024.

Juvena Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified